FALSINI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.010
EU - Europa 501
AS - Asia 183
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
Totale 1.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.008
IE - Irlanda 128
IT - Italia 118
PL - Polonia 102
SE - Svezia 87
CN - Cina 58
HK - Hong Kong 49
VN - Vietnam 40
JO - Giordania 21
ES - Italia 19
DE - Germania 12
GB - Regno Unito 10
FI - Finlandia 6
UA - Ucraina 6
RU - Federazione Russa 5
BE - Belgio 4
EU - Europa 4
SG - Singapore 4
IN - India 3
JP - Giappone 3
KR - Corea 3
NL - Olanda 3
CA - Canada 2
TR - Turchia 2
EE - Estonia 1
EG - Egitto 1
Totale 1.699
Salva come PNG Salva come JPEG
Città #
Fairfield 149
Chandler 141
Dublin 128
Warsaw 102
Ashburn 95
Woodbridge 74
Houston 71
Seattle 66
Cambridge 62
Wilmington 58
Florence 43
Dong Ket 40
Ann Arbor 36
Hong Kong 30
Princeton 29
Beijing 24
Altamura 23
Lawrence 23
Barcelona 17
Shanghai 17
Boston 14
Falls Church 11
Medford 11
San Diego 10
Gavirate 9
New York 8
Cagliari 7
Kent 7
Boardman 6
Jacksonville 6
Buffalo 5
Moscow 5
Brussels 4
Jinan 4
Parma 4
Norwalk 3
Pontassieve 3
Pune 3
Singapore 3
Camerino 2
Ferrara 2
Guangzhou 2
Hefei 2
Hillsboro 2
Icheon-si 2
London 2
Los Angeles 2
Nanjing 2
Redwood City 2
Stia 2
Toronto 2
Trumbull 2
West Jordan 2
Andover 1
Augusta 1
Böblingen 1
Cairo 1
Castelfranco di Sotto 1
Cavarzere 1
Chengdu 1
Chongqing 1
Chuxiong 1
Hebei 1
Islington 1
Kunming 1
Lappeenranta 1
Madrid 1
Misano Adriatico 1
Nottingham 1
Rotterdam 1
Seoul 1
Shaoxing 1
Stockholm 1
Tallinn 1
Urbino 1
Washington 1
Wuhan 1
Totale 1.403
Salva come PNG Salva come JPEG
Nome #
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 161
Design and synthesis of new adenosine receptor antagonists as neuroprotective agents 132
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 117
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 104
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 97
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 94
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 89
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 86
Development of novel pyridazinone-based adenosine receptor ligands 82
Design, synthesis, and pharmacological characterization of 2‑(2- furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity 81
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 71
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 69
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists 64
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A 1 and A 2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 60
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2Breceptor 58
2-Aryl-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as new potent adenosine human A2A receptor antagonists 54
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 50
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 46
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2Aadenosine receptor antagonists/inverse agonists 45
New aminopyridine-3,5-dicarbonitirles as adenosine A2B receptor non-nucleoside agonists. 44
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 43
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as dual human adenosine A2A/A1 receptor antagonists. 42
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 40
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 39
Totale 1.768
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.953
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020349 25 26 12 25 41 33 40 37 34 38 29 9
2020/2021277 10 30 3 33 18 14 7 16 33 48 22 43
2021/2022185 6 12 27 4 6 8 7 13 6 17 30 49
2022/2023522 43 90 45 30 36 96 62 44 56 0 15 5
2023/2024219 5 20 23 10 7 53 9 48 10 18 10 6
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.768